Impact of comorbidities on outcomes of elderly patients with diffuse large B-cell lymphoma
American Journal of Hematology Oct 19, 2017
Saygin C et al. - The international prognostic index (IPI) is the standard for prognostication of diffuse large B cell lymphoma (DLBCL) patients; however, the impact of co-morbidities in elderly patiens with DLBCL has not been established. In the current study it was shown that combining the IPI with the Charlson co-morbitidy index improves prognostication of elderly DLBCL patients.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries